bel & skar LLC

1 washington square village
apt 5f
new york, new york 10012

NYS Entity Status
ACTIVE

NYS Filing Date
AUGUST 23, 2013

NYS DOS ID#
4450065

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - BEL & SKAR LLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page
  • Go big in Bel Air: $100M mansion is our most expensive new listing
    By Claudine Zap, realtor.com - Sunday Jul 16, 2017

    Source: SFGATE.com: Real Estate News
  • Louisiana governor warns the worst of Harvey ‘is yet to come’
    By David K. Li - Monday Aug 28, 2017

    Louisiana Gov. John Bel Edwards warned residents Monday to batten down the hatches and brace for more turbulent weather as “the worst is yet to come.” As Tropical Storm Harvey regains strength in the Gulf of Mexico, torrential rains — and their accompanying floods — are expected to drench southern Louisiana on Wednesday, Thursday and...

    Source: New York Post: News
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed